the study population has not been selected correctly to validate EuroSCORE II performances. Namely, the study time span can negatively influence external validation of EuroSCORE II [3, 4] when applied to patients who underwent surgery before the period when EuroSCORE II was constructed and introduced in everyday cardiac surgical practice, back in 2012 [5]. Thus, performing EuroSCORE II validation on samples including patients operated before initiation of EuroSCORE II is potentially misleading [4]. Subsequently, is it logical to use EuroSCORE II to predict long-term mortality of noncontemporary cardiac surgical cohort, if it is questionable to use it even for prediction of operative mortality (for what it was basically constructed) for the same sample? The relationship between EuroSCORE II factors and longterm mortality showed that the most important effects were produced by low ejection fraction, salvage procedures, and dialysis, already well-known factors that influence long-term mortality. Therefore, in my opinion, it is a little bit pretentious to claim those factors as EuroSCORE II factors which influenced long-term mortality.